Beone Medicines Ltd (ONC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 227,357 | 286,933 | 220,431 | 95,590 | 1,270 |
| Depreciation Amortization | 41,144 | 141,686 | 105,702 | 68,418 | 32,804 |
| Income taxes - deferred | N/A | 9,469 | N/A | N/A | N/A |
| Accounts receivable | -75,300 | -164,954 | -167,294 | -73,369 | -31,866 |
| Accounts payable and accrued liabilities | -42,187 | 79,833 | -7,381 | -35,852 | -31,568 |
| Other Working Capital | -189,143 | 190,898 | 27,346 | -72,674 | -78,027 |
| Other Operating Activity | 239,465 | 583,715 | 531,429 | 325,567 | 151,469 |
| Operating Cash Flow | $201,336 | $1,127,580 | $710,233 | $307,680 | $44,082 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 27 | 3,446 | 1,800 | 1,800 | 1,800 |
| PPE Investments | -40,789 | -185,839 | -148,317 | -100,233 | -56,407 |
| Purchase Of Investment | N/A | -11,834 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -20,000 | -20,000 | -20,000 | N/A |
| Other Investing Activity | -4,748 | -81,928 | -91,303 | -90,113 | -67,334 |
| Investing Cash Flow | $-45,510 | $-276,155 | $-237,820 | $-188,546 | $-121,941 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 58,204 | 233,676 | 221,521 | 221,521 | 80,000 |
| Debt Issued | N/A | 850,586 | N/A | N/A | N/A |
| Debt Repayment | -7,641 | -35,680 | -21,062 | -16,799 | -4,215 |
| Common Stock Issued | 23,875 | 196,281 | 177,038 | 96,503 | 63,359 |
| Other Financing Activity | -5,806 | -185,412 | 585,023 | -299,977 | -172,921 |
| Financing Cash Flow | $68,632 | $1,059,451 | $962,520 | $1,248 | $-33,777 |
| Exchange Rate Effect | 19,320 | 60,024 | 36,862 | 26,957 | 3,480 |
| Beginning Cash Position | 4,609,647 | 2,638,747 | 2,638,747 | 2,638,747 | 2,638,747 |
| End Cash Position | 4,853,425 | 4,609,647 | 4,110,542 | 2,786,086 | 2,530,591 |
| Net Cash Flow | $243,778 | $1,970,900 | $1,471,795 | $147,339 | $-108,156 |
| Free Cash Flow | |||||
| Operating Cash Flow | 201,336 | 1,127,580 | 710,233 | 307,680 | 44,082 |
| Capital Expenditure | -40,789 | -185,839 | -148,317 | -100,233 | -56,407 |
| Free Cash Flow | 160,547 | 941,741 | 561,916 | 207,447 | -12,325 |